Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.

[1]  J. Higgins,et al.  Tenets for the Proper Conduct and Use of Meta-Analyses: A Practical Guide for Neurosurgeons. , 2022, World neurosurgery.

[2]  H. Yoshiji,et al.  Baveno VII - Renewing consensus in portal hypertension. , 2021, Journal of hepatology.

[3]  Hong Zhao,et al.  Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study , 2021, Frontiers in Medicine.

[4]  N. Befera,et al.  Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort. , 2021, Clinical imaging.

[5]  R. Moreau,et al.  The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. , 2020, Journal of hepatology.

[6]  E. Tapper,et al.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  Krishnakant V. Saboo,et al.  Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis. , 2020, The American journal of gastroenterology.

[8]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[9]  Y. Chan,et al.  Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis , 2019, World journal of gastroenterology.

[10]  A. Lok,et al.  Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis , 2019, Hepatology communications.

[11]  E. Kelly,et al.  Clinical Factors Associated with Mortality in Cirrhotic Patients Presenting with Upper Gastrointestinal Bleeding , 2019, Journal of the Canadian Association of Gastroenterology.

[12]  P. Andersen,et al.  Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[13]  Tony P. Smith,et al.  Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. , 2019, Journal of vascular and interventional radiology : JVIR.

[14]  A. Farcomeni,et al.  Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis , 2018, Hepatology.

[15]  Lifeng Lin,et al.  Quantifying publication bias in meta‐analysis , 2018, Biometrics.

[16]  M. Manns,et al.  Dose‐dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[17]  K. Jones,et al.  Fixed and random effects models: making an informed choice , 2018, Quality & Quantity.

[18]  Chen-Chi Tsai,et al.  Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding. , 2018, Clinics and research in hepatology and gastroenterology.

[19]  C. Tovo,et al.  Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis , 2017, World journal of hepatology.

[20]  R. Chung,et al.  Use of proton pump inhibitors in chronic liver diseases , 2017, Clinical liver disease.

[21]  Michelle L Degelman,et al.  Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation. , 2017, Multiple sclerosis and related disorders.

[22]  P. Hayes,et al.  The impact of proton pump inhibitor therapy on patients with liver disease , 2016, Alimentary pharmacology & therapeutics.

[23]  Ji-An Liang,et al.  Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis. , 2016, European journal of internal medicine.

[24]  Angela C. Poole,et al.  Proton pump inhibitors alter the composition of the gut microbiota , 2015, Gut.

[25]  Jingyuan Fu,et al.  Proton pump inhibitors affect the gut microbiome , 2015, Gut.

[26]  Nora C. Toussaint,et al.  Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial. , 2015, Gastroenterology.

[27]  Zachary A. Capshaw,et al.  Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology , 2015, Emerging Themes in Epidemiology.

[28]  K. Brandl,et al.  Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? , 2015, Expert review of gastroenterology & hepatology.

[29]  F. Barreyro,et al.  Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. , 2015, Journal of hepatology.

[30]  J. Turner,et al.  Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice , 2015, Hepatology.

[31]  B. Kronenberger,et al.  Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis , 2015, Alimentary pharmacology & therapeutics.

[32]  J. González-Navajas,et al.  Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis , 2015, Journal of gastroenterology and hepatology.

[33]  S. Bota,et al.  Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites , 2014, PloS one.

[34]  Y. Paik,et al.  Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study , 2014, Alimentary pharmacology & therapeutics.

[35]  Ji Won Kim,et al.  Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis , 2014, Journal of gastroenterology and hepatology.

[36]  P. Deltenre,et al.  Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[37]  Walter Wai-Yip Chan,et al.  Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  K. Reddy,et al.  Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end‐stage liver disease (NACSELD) experience , 2012, Hepatology.

[39]  K. Lapane,et al.  Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis , 2012, Alimentary pharmacology & therapeutics.

[40]  P. Siersema,et al.  Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability , 2012, European journal of clinical investigation.

[41]  K. Reddy,et al.  Immune dysfunction and infections in patients with cirrhosis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  R. Hoffmann,et al.  Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites , 2009, The American Journal of Gastroenterology.

[43]  John Fletcher,et al.  What is heterogeneity and is it important? , 2007, BMJ : British Medical Journal.

[44]  N. Shaheen,et al.  Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: A randomized, controlled trial , 2005, Hepatology.

[45]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[46]  R. Balbinot,et al.  ACUTE-ON-CHRONIC LIVER FAILURE IS INDEPENDENTLY ASSOCIATED WITH LOWER SURVIVAL IN PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS. , 2021, Arquivos de gastroenterologia.